Clinical Trial Update: Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip. [Phase 3]

View source ↗

Summary

Phase 3 multicenter study completed to assess safety and effectiveness of Anavip for snakebite envenomation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Snakebite Envenomation

Drugs mentioned

• Anavip (F(ab')2 antivenom)

Snippet

Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Snake Bite | Phase 3 | Status: COMPLETED